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Brown alga Fucus evanescens, widespread in the Far Eastern seas of Russia, is valuable
source of sulfated polysaccharides—fucoidans with beneficial biological activities. The
most homogenous fraction of fucoidan from F. evanescens was shown to be molecule
containing linear main chain of alternating 2-sulfated 1,3- and 1,4-linked α-L-fucose
residues. Few sulfate groups were found in position 4 of some 1,3-linked fucose residues.
Acetyl groups occupied free C-3 of 1,4-linked residues and/or the C-4 of 1,3-linked
fucose residues. Enzymatic hydrolysis, mild acid hydrolysis, and autohydrolysis of native
fucoidan were used for elucidation of the fine structural characteristics of fucoidan from
F. evanescens. The aim of this review to summarize published data on biological activities
of fucoidan from F. evanescens: antiviral, anticoagulant, thrombolytic, hepatoprotective,
immunomodulatory, anticancer, and their practical application.
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INTRODUCTION
Brown algae contain several compounds with biological activities: polysaccharides, iodine
organic products, mannitol, macro- and micro-elements, vitamins, unsaturated fatty acids, and
other biogenic compounds. The aqueous ethanol extracts of the brown alga Fucus evanescens
were enriched with tyrosine and phenylalanine (these amino acids are precursors of thyroxin
biosynthesis in humans), proteins, phenol compounds, and chlorophyll (Imbs et al., 2009). In
addition, F. evanescens is a promising source of fucoxanthin (Imbs et al., 2013). We present data
about the structure, biological activities, and practical application of sulfated polysaccharide—
fucoidan—from the F. evanescens.
We did not aim to compare the data about fucoidans from F. evanescens with fucoidans from
other Fucus species, as there are published a number of reviews on various fucoidans. It is also
difficult to compare our data with the data for fucoidans from other Fucus species, because
the authors often use commercial products which are not structurally characterized completely.
It is known that structural characteristics of fucoidans depend on the method of isolation and
fractionation of the polysaccharides. The comparison with commercially available fucoidan from
Fucus vesiculosus is not quite correct, because it contains a lot of impurities (Nishino et al., 1994).
We wanted that results about investigations of fucoidans from F. evanescens were accessible to
other researchers, since most of the results were published in Russian journals.
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STRUCTURE OF FUCOIDANS FROM
FUCUS EVANESCENS
The brown alga F. evanescens belongs to the family Fucaceae of
the order Fucales. Fucoidans obtained from the alga of this family
are sulfated fucans with a main chain of alternating residues of
1,3- and 1,4-linked α-L-fucose (Chevolot et al., 2001; Bilan et al.,
2004, 2006).
Studies of the fucoidan content in F. evanescens, which
depends on the location of algal harvest and on the conditions
of the polysaccharide extraction procedure, were performed by
our group (Table 1; Zvyagintseva et al., 2003). We found that this
alga contained the highest fucoidan content compared to that
of other brown algae harvested from the Sea of Okhotsk and
Sea of Japan: Saccharina cichorioides, Saccharina japonica, and
Saccharina gurjanovae.
The structure of fucoidan from F. evanescens was studied
by two research groups: Zvyagintseva et al. (Zvyagintseva
et al., 2003; Kusaykin et al., 2006; Anastyuk et al., 2009,
2012; Silchenko et al., 2014) and Bilan et al. (2002). In this
investigation (Bilan et al., 2002), crude fucoidan was obtained
and separated into five fractions. The most homogenous fraction
was chosen for structure elucidation. This fraction contained
fucose, sulfate, and acetyl groups at a molar ratio of 1:1.23:0.36
and trace amounts of galactose and xylose. The desulfation
and deacetylation of fucoidan were carried out to simplify the
polysaccharide structure. The structures of the obtainedmodified
fucoidans were studied by 1D (1H, 13C) and 2D (COSY, TOCSY,
ROESY, NOESY, HSQC, and HMBC) NMR spectroscopy and
methylation analysis. As a result, fucoidan was shown to be a
regular molecule containing disaccharide repeating units, with a
linear main chain of alternating 2-sulfated 1,3- and 1,4-linked α-
L-fucose residues. A methylation analysis of desulfated fucoidan
showed that 1,3- and 1,4-linked fucose residues had a ratio of
1.2:1. Few sulfate groups were found in position 4 of some 1,3-
linked fucose residues. Acetyl groups occupied the free C-3 of
1,4-linked residues and/or the C-4 of 1,3-linked fucose residues
(Figure 1A). It was shown that xylose residues were not linked to
fucose and belonged to 1,4-β-D-xylan.
It is known that each alga can synthesize fucoidans of
various structures. For example, 16 fractions of fucoidans with
different contents of 1,3- and 1,4-α-L-fucose residues and degrees
of sulfation and acetylation were obtained from commercially
available fucoidans from F. vesiculosus, which is widely used for
the study of biological activities of polysaccharides(Honya et al.,
1999; Ale et al., 2011; Fitton, 2011; Fitton et al., 2015).
TABLE 1 | The fucoidan content in the brown alga Fucus evanescens inhabiting different regions of the Sea of Okhotsk (Zvyagintseva et al., 2003).
Location/time of algae collection The alga dry weight, % LMW substances*, % of alga dry weight Fucoidan, % of defatted alga weight
Cold extraction Hot extraction
Sea of Okhotsk, Kraternaya Bay, August 23 23 12.0 9.0
Sea of Okhotsk, Paramushir Island, August 22 21 4.8 8.8
Sea of Okhotsk, Iturup Island, August 19 20 5.3 9.7
*Low-molecular-weight substances extracted by 40% ethanol.
We developed a scheme to purify water-soluble
polysaccharides from brown algae and to obtain the fraction of
fucoidan from F. evanescens with other structural characteristics
compared to those of the fucoidan mentioned above (Bilan et al.,
2002). According to our data (Kusaykin et al., 2006), fucose and
sulfate groups were found at a ratio of 1:0.43. This fraction also
contained trace amounts of other monosaccharide residues. A
methylation analysis of desulfated fucoidan showed that 1,3-
and 1,4-linked fucose residues had a ratio of 3.5:1. Thus, this
fraction was distinguished by higher contents of 1,3-linked
fucose residues.
To elucidate the fine structural characteristics of fucoidan
from F. evanescens, we used enzymatic hydrolysis, low-
acid hydrolysis, and autohydrolysis of native fucoidan
(Silchenko et al., 2014). Native fucoidan from F. evanescens
was depolymerized using fucoidanase from the Vietnamese
marine mollusk Lambis sp., which was specific for the α-1,4-O-
glycosidic bonds. The products of enzymatic hydrolysis were
separated into high- and low molecular weight (HMW and
LMW) fractions. The LMW fraction (yield 73%) was fractionated
by anion-exchange chromatography to obtain fractions 1, 2, 3,
4, and 5 with yields of 3.6, 4.0, 5.4, 13.7, and 15.8%, respectively.
Structures of the more homogenous fractions 3, 4, and 5 were
investigated by 1D (1H, 13C) and 2D (COSY, TOCSY, HSQC,
and HMBC) NMR spectroscopy. Consequently, fucoidan from
F. evanescens had a small amount (∼2%) of single 1,4-linked
fucose residues in the branches at C-4 of 1,3-linked fucose
residues of the main chain. Fraction 3 mainly contained sulfated
disaccharide, fraction 5 contained sulfated linear tetrasaccharide,
and fraction 4 contained sulfated branched pentasaccharide;
the other components of these fractions were present in trace
amounts. These observations correlated with the data from
the mass spectrometry analysis. Structures of fractions 3, 4,
and 5 were characterized as α-L-Fucp-2-OSO−3 -(1,3)-α-L-Fucp-
2-OSO−3 , α-L-Fucp-2-OSO
−
3 -(1,3)-;α-L-Fucp-(1,4)-α-L-Fucp-
2-OSO−3 -(1,4)-α-L-Fucp-2-OSO
−
3 -(1,3)-α-L-Fucp-2-OSO
−
3 ,
and α-L-Fucp-2-OSO−3 -(1,3)-α-L-Fucp-2-OSO
−
3 -(1,4)-
α-L-Fucp-2-OSO−3 -(1,3)-α-L-Fucp-2-OSO
−
3 , respectively
(Figure 1B).
In addition, fucoidan was depolymerized under solvolytic
conditions, and the LMW fraction was analyzed by MALDI-TOF
MS and ESI MS/MS. It was shown that fuco-oligosaccharides
(DP = 2–4) mainly had sulfation at C-2 and a prevalence of
1,3-linkages over the 1,4-linkages. Xylose and galactose residues
were found to be associated with fucose residues in the followed
fragments: Xyl-(1,4)-Fuc, Gal-(1,4)-Fuc, Gal-(1,4)-Gal-(1,4)-Fuc,
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FIGURE 1 | Structures of fucoidan from F. evanescens (A) and products of its enzymatic hydrolysis (B).
and Gal-(1,4)-Gal. Fucose, galactose, and xylose residues
were sulfated mainly at C-2 and less frequently at C-4.
Residues of glucuronic acid were found in the composition
of non-sulfated fucooligosaccharides: Fuc-(1,3)-GlcA, Fuc-
(1,4)-Fuc-(1,3)-GlcA, and Fuc-(1,3)-Fuc-(1,4)-Fuc-(1,3)-GlcA
(Anastyuk et al., 2009). In the next study, fucoidan was
depolymerized by autohydrolysis, and the LMW fraction
was analyzed by MALDI-TOF MS (Anastyuk et al., 2012).
Mass spectrometry analysis showed the presence of galactose-
containing fragments with the following structures: Gal-2-
OSO3Na-(1,3)-Gal-2-OSO3Na, Gal-2,4-OSO3Na-(1,4)-Fuc, and
Fuc-2-OSO3Na-(1,4)-Gal-2-OSO3Na.
Our results show that the intensity of the biosynthesis of
fucoidan may significantly depend on the algae habitats. A
structural investigation of fucoidan from F. evanescens with
enzymatic, chemical, and physical methods allowed us to
determine that the minor components, such as Xyl, Gal, and
GlcA, are part of the fucoidan molecules from F. evanescens.
This part of the review was devoted to the structural
investigation of fucoidans from F. evanescens and to the
determination of the location of their minor structural
elements. According to the literature, fucoidans are
multifunctional polysaccharides (Ermakova et al., 2015).
They possess a broad spectrum of biological activities:
antiviral, anticoagulant, thrombolytic, hepatoprotective,
immunomodulatory, and anticancer. Our aim was to
summarize published data about the biological activities
of fucoidans from F. evanescens and their practical
application.
BIOLOGICAL ACTIVITY AND APPLICATION
Antiviral Activity
Fucoidans have antiviral activity against several viruses: hepatitis
C virus, influence virus, Newcastle disease virus, tick-bone
encephalitis virus, Dengue virus, hemorrhagic fever with renal
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syndrome virus, and viruses of the Herpesviridae family (Fitton,
2011; Fitton et al., 2015).
It was found that fucoidan from F. evanescens has no cytotoxic
effects on Jurkat and SC-1 cells within a concentration range
of 0.001–100 µg/mL. The activity of fucoidan against lentiviral
transduction of the Jurkat cells by pseudo-HIV-1 particles with
HIV-1 gr120+gp41 or particles containing the G envelope
protein from vesicular stomatitis virus (VSV) was studied. These
viruses have different mechanisms of cell penetration. Fucoidan
inhibits the lentiviral transduction of Jurkat cells by pseudo-
HIV-1 particles with the HIV-1 gr120+gp41 envelope protein
at 10 µg/mL. The removal of acetyl groups leads to a decrease
in the molecular mass of polysaccharides (from 620 to 20
kDa) and their inhibitory activity (IC50 changed from 0.01 to
0.52 µg/mL). In addition, native and deacetylated fucoidans
suppressed the infection of SC-1 cells by Mo-MuLV in the
same manner (IC50 changed from 0.006 to 4.5 µg/mL). The
fucoidan from F. evanescens did not provide a strong inhibition
of antiviral activity against pseudo-HIV-1 particles with the
envelope protein G of VSV (from 0.1 to 10 µg/mL). These data
demonstrate the specific activity of fucoidan from F. evanescens
against HIV-1 (Prokofjeva et al., 2013). Fucoidan from Fucus
vesiculosus (0.1 µg/mL) possessed inhibitory action on HIV-1
reverse transcriptase (Queiroz et al., 2008).
Fucoidan from F. evanescens exhibited antiviral activity
against Hantaan virus (Makarenkova et al., 2008). In vitro,
fucoidan from F. evanescens (100–1000µg/mL) showed virucidal
and protective action on cells that were infected with tick-borne
encephalitis (Makarenkova et al., 2012a).
Tobacco mosaic virus (TMV) can induce mosaic, mottled,
necrotic, stunted, curled-leaf, and yellowing plant tissues.
Fucoidan from the brown alga F. evanescens (1mg/mL) inhibited
more than 90% of the spread of an infection induced by TMV
in tobacco leaves (Nicotiana tabacum L.) of two cultivars: Ksanti-
nk and Samsun (Lapshina et al., 2006). However, the inhibitory
effect of fucoidan decreased as the infection spread. Fucoidan
directly affected the virus: agglutinated virions were found by
electron microscopy in the mixture of TMV (2 µg/mL) with
fucoidan (1mg/mL). It was established that the effect of fucoidan
on the plant occurred at the genetic level: the processing of
tobacco leaves cv. Ksanti-nk with actinomycin D (10 µg/mL) for
24 h before inoculation with TMV infection almost completely
inhibited the antiviral effect of fucoidan (Lapshina et al.,
2007). The significance of this discovery is that it shows the
biotechnological potential of fucoidan from F. evanescens.
Anticoagulant Activity
The anticoagulant activity of fucoidan from F. evanescens and
another 10 brown algae from the Far Eastern part of Russia was
determined by measuring the activated partial thromboplastin
time (APTT), prothrombin time, and thrombin time. The
mechanism of their anticoagulant effect was investigated on the
activity of key enzymes of blood coagulation: thrombin and
factor Xa. Regarding the most active fucoidan from Laminaria
saccharina, the concentration required for the 50% inhibition
of thrombin (IC50) was 8.3 µg/mL in the absence of AT III
and 0.6 µg/mL in the presence of AT III. For the fucoidan
from F. evanescens, IC50 was 9.4 µg/mL and 1.1 µg/mL. For
comparison, effectiveness of binding (IC50) of fucoidan from
F. vesiculosus to thrombin in the presence of ATIII was 2.1
µg/mL (Ustyuzhanina et al., 2013). All investigated fucoidans
interact with AT III and promote thrombin activation, similar
to heparin; however, in contrast to heparin, they may directly
inhibit thrombin. Fucoidan from F. evanescens, similar to all of
the examined fucoidans (except for fucoidan from Laminaria
saccharina), weakly inhibited factor Xa in the presence of AT
III, in contrast to heparin. None of studied fucoidans inhibited
Xa in the absence of AT III. The authors concluded that the
anticoagulant activity of the investigated fucoidans did not
depend directly on contents of fucose and other neutral sugars
or on the structure of the main chain (Ushakova et al., 2009).
Another group calculated the ratio of the inhibitory activity
of fucoidan from F. evanescens aXa/aIIa as 1.3–2.3. The effect of
fucoidan on the fibrinolysis system was observed by activating
the endogenous fibrinolytic system of blood. It was found that
the effect of this fucoidan as an anticoagulant in vitro and in vivo
was comparable to the effect of heparin. It should be noted that
the anticoagulant activity of fucoidan by its oral administration
(5 and 10mg/kg) in the studied doses is weak and recorded
as immunotropic activity with parenteral and oral routes of
administration (Kuznetsova et al., 2003a,b). The intravenous
administration of fucoidan from F. evanescens to rats causes
a dose-dependent increase in the plasma anticoagulant activity
(Maistrovsky et al., 2010a).
Quantitative differences in the action of fucoidans may result
from different sulfation degrees and the presence of various
types of glycoside bonds in polysaccharide molecules (Drozd
et al., 2006, 2011a,b; Kuznetsova et al., 2006). To investigate
effect of fine elements of the structure of fucoidan from
F. evanescens on anticoagulant activity, the preparations of
fucoidan without protein and polyphenols, as well as deacetylated
and depolymerized, were obtained. The deacetylation of fucoidan
did not change ability of fucoidan to inhibit thrombin and Xa
factor, while removing proteins and polyphenols decreased the
polysaccharide activity. The depolymerization of fucoidan cause
an increase in the ability to inhibit thrombin predominantly by
heparin cofactor II. All of the investigated samples formed a
complex with protamine sulfate (Lapikova et al., 2008).
For fractionated fucoidans from F. vesiculosus were showed
that fucoidan with charge density of 0.5 sulfates per sugar unit
and a size of 70 sugar units demonstrate desired procoagulant
activities for improvement of haemostasis in factor VIII/factor
IX-deficient plasma (Zhang et al., 2014).
The combination of the immunomodulating properties of the
fucoidan from F. evanescens with their anticoagulant activity is
promising for improving hemorheology and microcirculation
and for reducing tendency to thrombosis during surgery and
treatment (injury, combined lesions, intoxication, septicemia,
and infectious diseases), as well as secondary immune deficiency.
Hepatoprotective Activity
Fucoidans showed a corrective effect on indicators of lymphocyte
activation in patients with hepatitis C. Patients received the
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standart theraphy and the standard therapy with fucoidan from
F. evanescens added (Filonova et al., 2010).
The hepatoprotective effect of fucoidan (oral administration)
in experimental chronic toxic hepatitis in mice induced by
carbon tetrachloride was registered with magnetic resonance
and biochemical analysis. The oral administration of fucoidan
led to the normalization of morphological structure and
functional state of the liver. The obtained results demonstrate the
hepatoprotective activity of fucoidan and open up new prospects
for its clinical application in the treatment of hepatitis C.
Fucoidan has low toxicity and is soluble in water and acidic
solutions. Currently, the fucoidan from F. evanescens has been
standardized and produced in sufficient quantities for research,
production of food supplements, and preclinical testing. This
polysaccharide regulates the humoral and cellular factors of
innate and acquired immunity (Kuznetsova et al., 2010).
The effect of fucoidan extracted from F. evanescens on
endotoxin-induced damage in a mouse model of endotoxemia
was studied. The results of this investigation demonstrate its
preventive effect. The administration of fucoidan (parenteral or
per os) increased the survival times of mice, led to the inhibition
the increasing levels of proinflammatory cytokines (TNFα and
IL-6), and attenuated hypercoagulation and microcirculatory
disorders and secondary dystrophic-destructive changes in
the liver, kidneys, lungs, and hearts of mice. In addition,
fucoidan effectively regulated the immunity and hemostasis
systems in experimental endotoxemia, attenuated the course
of disseminated intravascular coagulation (DIC) syndrome,
prevented endotoxin-induced damage in a mouse model of
endotoxemia, and in the long term, has the potential for the
development of a drug to reduce of the negative effects of
endotoxin (Kuznetsova et al., 2014).
Effect on the Complement System
The increased or decreased activation of alternative pathway
of complement (APC) is frustrating for the organism.
Especially dangerous is its increased uncontrolled activation of
autoimmune complexes, which are capable of causing damage to
the organism’s own cells. Therefore, it is important to search for
new physiologically active substances with a corrective process
to activate the complement system.
Fucoidans from F. evanescens, L. cichorioides, and L. japonica
were used to study the effect of water-soluble polysaccharides
from brown algae on APC. Highly sulfated fucoidan II
from L. cichorioides showed the highest activity toward APC
(IC50 = 0.7mg/mL), for fucoidan II from F. evanescens IC50
= 9.2mg/mL, and for fucoidan from L. japonica IC50 =
20mg/mL. The authors used preparations of fucoidans with
different sulfate group contents, and it was shown that this
structural characteristic was not important for the activation
of APC. The laminarans (1,3:1,6-β-D-glucans) from these algae
were not active in this test. This finding supports the positive
influence of fucose residues on the structure of polysaccharides
for the activation of APC. This study demonstrates that fucoidan
from F. evanescens is inhibitor of human complement activation
in vitro (Zvyagintseva et al., 2000).
Fucoidan as Modificator of Enterosorbent
Fucoidan from F. evanescens was examined for the creation of a
new immune enterosorbent (Konenkov et al., 2008). The surface
of modified sorbent contains hydrophilic centers due to alumina,
polar fragments of the polysaccharide, and hydrophobic regions
of carbon sorbent. This composition allows the binding of highly
toxic substances and provides a detoxifying effect of the sorbent.
In addition, the porous structure of the sorbent and the nature
of the chemical centers (weak acidic or basic centers) provide its
prolonged escape and synergistic hepatoprotective effect.
Immunomodulatory hepatoprotective effects of the new
immune enterosorbent and its beneficial effect on the mucous
membrane of the gut were shown in vivo. It is possible to use
the new sorbent for the treatment of patients with purulent
septic diseases (Konenkov et al., 2008). The modified sorbent as
the basis of medical dressings and medical creams and as part
of complex medical devices can be used as a hemosorbent or
enterosorbent or as a carrier for enzymes, cells and biologically
active substances, promoting their prolonged action.
Anticancer Activity
The ability of fucoidan from F. evanescens to increase the
apoptosis induced by etoposide (inhibitor of DNA topoisomerase
II) was investigated. It has been shown that the incubation of
MT-4 but not Namalwa cells in the presence of a highly purified
preparation of fucoidan (500 µg/mL) increases the sensitivity of
these cells to etoposide with the subsequent induction of caspase-
3-independent pathways of apoptosis. The results suggested
a new role for fucoidan: the combination of fucoidan with
approved anticancer drugs for a synergistic effect (Philchenkov
et al., 2006, 2007). Commercially available crude fucoidan from
the brown seaweed F. vesiculosus (Sigma-Aldrich) became very
attractive, in spite of the absence of sufficient data on its exact
structure. A number of researchers used this product without
any purification. Thus, it was demonstrated fucoidan from
F. vesiculosus induced apoptosis of human lymphoma HS-Sultan
cells (Aisa et al., 2005), myeloid leukemia U937 cells (Park
et al., 2013), and HL-60, NB4, THP-1 cells (Jin et al., 2010)
via the activation of caspase-9 and -3 accompanied by down-
regulation of Bcl-2 and Bax expression, as well as changes in the
phosphorylation of ERK, JNK, p38, and Akt kinases.
The antitumor and antimetastatic activities of fucoidan
from F. evanescens were investigated in vivo using mice
with transplanted Lewis lung adenocarcinoma (C57Bl/6 mice).
Fucoidan (10mg/kg) alone possess moderate antitumor and
antimetastatic effects. In addition, this fucoidan potentiates the
antimetastatic but not antitumor activities of cyclophosphamide
(drug used for chemotherapy) and, at 25mg/kg, increases the
toxic effect of cyclophosphamide (Alekseyenko et al., 2007).
The fucoidan from F. vesiculosus (20 µg/mL) synergistically
reduced cell growth in the EGFR/ERBB2-amplified cancer cell
line (OE33) when it was combined with lapatinib, a targeted
therapy that acts as a tyrosine kinase inhibitor in advanced
HER2-positive breast cancer cells (Oh et al., 2014). The in
vitro anticancer activity (soft agar model) of fucoidans derived
from nine brown algae species was studied. The fucoidan from
F. evanescens (200 µg/mL) was nontoxic to DLD-1 and HT-29
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cells and inhibited their colony formation (DLD-1 at 50% and
HT-29 at 30%; Vischuk et al., 2009). Several authors investigated
the effect of fucoidans from F. vesiculosus on colorectal cancer
growth. The fucodan was shown to suppress growth of human
colon carcinoma HCT-15 cells on 62% at concentration 100
µg/ml (Hyun et al., 2009), and to induce substantial reductions
in viable cell numbers of HT-29 and HCT116 at dose 20 µg/ml
(Kim et al., 2010). On other hand, Han et al. examined the
growth inhibiting effect of the same fucoidan on HT-29 cells.
The cell growth was found to be significantly decreased following
treatment with polysaccharide (200 µg/ml; Han et al., 2015).
Because of the heterogeneity in structural characteristics within
seaweed, differing extraction conditions used by researchers can
give rise to the isolation of distinct fucan forms (Li et al., 2008).
This fact can explain difference in doses of fucoidan using for the
treatment of the same cell lines. This fucoidan (400 µg/mL) was
also nontoxic to the melanoma cell lines SK-Mel-5 and SK-Mel-
28 and inhibited the cell proliferation (48 h) of these cells in a
dose-dependent manner. The fucoidan from F. evanescens (800
µg/mL) inhibited the colony formation of SK-MEL-5 (63%) and
SK-MEL-28 (70%) cells, and the content of α-1,4-fucose residues
in the fucoidan molecule is important for its inhibiting activity
(Anastyuk et al., 2012).
The cancer-preventive efficacy of the fucoidan from
F. evanescens in vitro and ex vivo was investigated. Fucoidan
participates in the prevention of neoplastic cell transformation
and in the progression of colon carcinomas through lymphokine-
activated killer T-cell-originated protein kinase (TOPK; Vishchuk
et al., 2016).
Immunomodulatory Activity
Fucoidan activates innate immune cells and can protect
organisms against pathogenic microorganisms (Makarenkova
et al., 2008). The mechanism of the stimulating effect of
fucoidan from F. evanescens on immune cells was associated
with an enhanced induction of cytokines by dendritic cells (DC;
Makarenkova et al., 2010; Khilchenko et al., 2011) and with the
maturation of the DC through the downregulation of scavenger
receptor class-A type I and type II (SR-A; Jin et al., 2009;
Zviagintseva et al., 2009).
Fucoidans enhance the induction of cytokines by dendritic
cells (DC) in vitro (Makarenkova et al., 2010) and the maturation
of the blood DC through the downregulation of scavenger
receptor class-A type I and type II (SR-A; Jin et al., 2009).
Fucoidan-induced maturation was eliminated by pretreatment
with a TNF-α antibody. Specific inhibitors of p38 MAPK and
glycogen synthase kinase 3 suppressed the TNF-a production
and maturation of fucoidan-treated peripheral blood dendritic
cells. Fucoidan from F. evanescens is effective inductor of the
maturation of DC and of enhanced T cell stimulatory capacity
(Jin et al., 2009; Zviagintseva et al., 2009). Our date have a good
correlation with results obtained for fucoidan from F. vesiculosus
(Kim and Joo, 2008).
Fucoidans from F. evanescens, Laminaria japonica, and
Laminaria cichorioides possess immunotropic activity and can
protect organisms against pathogenic microorganisms. These
fucoidans are independent ligands for TLRs. The investigated
fucoidans specifically interacted with TLR 2, TLR 4, and the
heterodimer TLR 2/6. This interaction resulted in the activation
of the transcription nuclear factor NF-κB, which is crucial for the
formation of an immune response on the Th1 type (Makarenkova
et al., 2012b,c). In addition, fucoidan from F. evanescens (from
10 to 100 µg/mL) can delay (but not suppress) in vitro cell
death after UVB irradiation (human skin fibroblast HS68 and
immortalized human keratinocyte HaCaT). An investigation of
the mechanism of this activity indicated that fucoidans inhibit
MMP-1 promoter activity and expression (Moon et al., 2008,
2009; Ku et al., 2010).
The influence of fucoidans from F. evanescens, L. cichorioides,
and L. japonica (500 µg/mL) on the apoptosis of human
peripheral blood lymphocytes was studied. The investigated
fucoidans induced lymphocyte apoptosis through the
mitochondrial pathway: they increased the proportion of
cells with a low mitochondrial transmembrane potential and
inhibited the expression of the Bcl-xL gene in blood lymphocytes
(Gazha et al., 2015).
Antioxidant Activity
Fucoidans have been reported to show high antioxidant activity
(Hu et al., 2010; Costa et al., 2011; Rodriguez-Jasso et al.,
2014). The antioxidant properties of fucoidans are defined
by their structural characteristics and are notably related
to their molecular weight (Xue et al., 2001). The chemical
composition of the sulfated polysaccharides that were extracted
from F. evanescens is affected by the extraction method (Imbs
et al., 2015a). The fractions of fucoidans from F. evanescens
obtained by different extraction methods had different amount
of polyphenols. The antioxidant activity of these fucoidans
was strongly correlated with polyphenol content but not with
sulfation degree or the uronic acid and fucose contents. It is
likely that pure fucoidans do not possess antioxidant activity
and that the activity observed is due to the presence of
polyphenols.
Clinical Trials of Food Supplement Base of
Fucoidan
At the G.B. Elyakov Pacific Institute of Bioorganic Chemistry of
the Far Eastern Branch of the Russian Academy of Sciences, the
fucoidan from F. evanescens was used to create the first Russian
food supplement based on fucoidan: “Fucolam R©.” “Fucolam R©”
possesses all of the properties that have been established for
fucoidan from F. evanescens.
Clinical investigations using volunteers have shown that the
application of “Fucolam R©” for the treatment of patients with
arteriosclerosis leads to the normalization of the cholesterol
distribution among lipoprotein fractions and to a reduced
atherogenic index (Maistrovsky et al., 2010b; Kryzhanovsky et al.,
2014; Imbs et al., 2015b).
Prebiotics must have resistance to the absorption and activity
of enzymes in the upper gastrointestinal tract and must provide
species selectivity. The prebiotic potential of fucoidans was
investigated in vitro and in vivo (Maistrovskiy et al., 2009). The
results of this study indicate that fucoidan from F. evanescens do
not digest in the upper gastrointestinal tract and stimulate the
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growth of bifidobacteria (3–5.8 times compared to that of the
control) on a medium enriched with fucoidan (Kuznetsova et al.,
2012). Thus, we created “Bifidomarin”—new symbiotic sour milk
beverage with B. bifidum (Kuznetsova et al., 2012). “Bifidomarin”
can be used in a variety of patients with gastrointestinal tract
disorders. This sour milk drink normalizes microbiocenosis and
restores both the immune and methanolic statuses (Zaporozhets
et al., 2014).
The possible applications of fucoidan from F. evanescens are
varied. Our investigations demonstrate the significant potential
of “Fucolam R©” and “Bifidomarin” as supplements to improve
human health.
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